Paid Clinical Trials Des Moines

Discover 277 paid clinical trials in Des Moines, Iowa. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 277

Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis

Recruiting

PHASE2

Sponsor:

Kowa Research Institute, Inc.

Location:

Clive, Columbia, Jefferson City, Conwayshow 42 more

Code:

NCT05327127

Conditions

NASH

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

K-877-ER

CSG452

Placebo

Enlighten Study: The EV-ICD Post Approval Registry

Recruiting

Sponsor:

Medtronic

Location:

West Des Moines, Rochester, Kansas City, Minneapolisshow 47 more

Code:

NCT06048731

Conditions

Ventricular Arrhythmia

Tachycardia

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Defibrillation using EV-ICD

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Recruiting

PHASE2

Sponsor:

National Cancer Institute (NCI)

Location:

Des Moines, West Des Moines, Clive, Amesshow 350 more

Code:

NCT03866382

Conditions

Bladder Adenocarcinoma

Bladder Clear Cell Adenocarcinoma

Bladder Mixed Adenocarcinoma

Bladder Neuroendocrine Carcinoma

Bladder Small Cell Neuroendocrine Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Bone Scan

Cabozantinib S-malate

Computed Tomography

Echocardiography

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

Recruiting

PHASE2

Sponsor:

SWOG Cancer Research Network

Location:

Ames, Boone, Jefferson, Marshalltownshow 69 more

Code:

NCT06116682

Conditions

Lung Non-Small Cell Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Amivantamab

Biospecimen Collection

Computed Tomography

Magnetic Resonance Imaging

Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors

Recruiting

PHASE2

Sponsor:

SWOG Cancer Research Network

Location:

Des Moines, West Des Moines, Clive, Amesshow 210 more

Code:

NCT05040360

Conditions

Metastatic Malignant Neoplasm in the Liver

Pancreatic Neuroendocrine Tumor

Stage I Pancreatic Neuroendocrine Tumor AJCC v8

Stage II Pancreatic Neuroendocrine Tumor AJCC v8

Stage III Pancreatic Neuroendocrine Tumor AJCC v8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Capecitabine

Temozolomide

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

Recruiting

PHASE3

Sponsor:

National Cancer Institute (NCI)

Location:

Des Moines, West Des Moines, Clive, Ankenyshow 395 more

Code:

NCT04181060

Conditions

Advanced Lung Non-Squamous Non-Small Cell Carcinoma

Metastatic Lung Non-Squamous Non-Small Cell Carcinoma

Recurrent Lung Non-Squamous Non-Small Cell Carcinoma

Stage IIIB Lung Cancer AJCC v8

Stage IV Lung Cancer AJCC v8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Bevacizumab

Biospecimen Collection

Computed Tomography

Echocardiography

Magnetic Resonance Imaging

Testing Nivolumab and Ipilimumab Immunotherapy With or Without the Targeted Drug Cabozantinib in Recurrent, Metastatic, or Incurable Nasopharyngeal Cancer

Recruiting

PHASE2

Sponsor:

National Cancer Institute (NCI)

Location:

Des Moines, Clive, Ankeny, Council Bluffsshow 58 more

Code:

NCT05904080

Conditions

Metastatic Nasopharyngeal Carcinoma

Recurrent Nasopharyngeal Carcinoma

Stage IV Nasopharyngeal Carcinoma AJCC v8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Cabozantinib S-malate

Computed Tomography

Ipilimumab

Magnetic Resonance Imaging

Study of Chemotherapy Plus Ipatasertib for People With Solid Tumors With PTEN/AKT Mutations, A ComboMATCH Treatment Trial

Recruiting

PHASE2

Sponsor:

National Cancer Institute (NCI)

Location:

Des Moines, Ankeny, Rochester, La Crosseshow 159 more

Code:

NCT05554380

Conditions

Locally Advanced Malignant Solid Neoplasm

Metastatic Malignant Solid Neoplasm

Unresectable Malignant Solid Neoplasm

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biopsy

Biospecimen Collection

Computed Tomography

Ipatasertib

Magnetic Resonance Imaging

A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma

Recruiting

PHASE3

Sponsor:

BeiGene

Location:

Des Moines, Columbia, Topeka, Grand Islandshow 61 more

Code:

NCT05100862

Conditions

Relapsed/Refractory Follicular Lymphoma

Marginal Zone Lymphoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Zanubrutinib

Rituximab

Lenalidomide

Obinutuzumab

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

Recruiting

Sponsor:

Medtronic

Location:

West Des Moines, Omaha, Rochester, Kansas Cityshow 106 more

Code:

NCT00271180

Conditions

Arrhythmia

Bradycardia

Heart Failure

Sinus Tachycardia

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Device